open access
Systemic complications in the hormonal treatment of prostate and breast cancer
- Department of Diagnostic Oncology and Cardioncology, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warszawa, Poland
open access
Abstract
Oncological treatment is often associated with a wide range of adverse effects. The article focuses on systemic complications that may occur during the hormonal therapy of prostate and breast cancer. Considering that current treatments are increasingly effective, the number of patients suffering from early and remote complications of cancer therapy can be expected to rise. Many undergo radical treatment and in this group in particular, close attention should be paid to the prevention, early diagnosis, and treatment of adverse effects. Hormonal disorders and their complications considerably affect the quality of life and life expectancy by upsetting general systemic homeostasis.
Abstract
Oncological treatment is often associated with a wide range of adverse effects. The article focuses on systemic complications that may occur during the hormonal therapy of prostate and breast cancer. Considering that current treatments are increasingly effective, the number of patients suffering from early and remote complications of cancer therapy can be expected to rise. Many undergo radical treatment and in this group in particular, close attention should be paid to the prevention, early diagnosis, and treatment of adverse effects. Hormonal disorders and their complications considerably affect the quality of life and life expectancy by upsetting general systemic homeostasis.
Keywords
aromatase inhibitors, tamoxifen, androgen antagonists, side effects of medication, prostate cancers, breast cancers
Title
Systemic complications in the hormonal treatment of prostate and breast cancer
Journal
Nowotwory. Journal of Oncology
Issue
Article type
Review paper
Pages
206-214
Published online
2017-12-12
Page views
742
Article views/downloads
869
DOI
Bibliographic record
Nowotwory. Journal of Oncology 2017;67(3):206-214.
Keywords
aromatase inhibitors
tamoxifen
androgen antagonists
side effects of medication
prostate cancers
breast cancers
Authors
Beata Jagielska
Grażyna Poniatowska
Konrad Tałasiewicz
Tomasz Demkow
Paweł Wiechno